Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Roswell Park Cancer Institute
CTI BioPharma
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Boston Children's Hospital
Dana-Farber Cancer Institute
Nohla Therapeutics, Inc.
Case Comprehensive Cancer Center
University of Washington
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
University of Rochester
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Asan Medical Center
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
Mesoblast, Ltd.
Cellerant Therapeutics
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Chicago
Children's Oncology Group
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)